In Part 1 of this series, we covered the basics—premiums, deductibles, co-insurance, and out-of-pocket maximums. But if you’re an HR professional or business leader tasked with evaluating or managing your company’s health plan, understanding the next layer of terminology is essential. These are the terms that can dramatically impact cost, quality, and transparency—and they often fly under the radar.

In Part 2, we’re breaking down four more advanced—but critical—terms you should understand to make smarter, more strategic benefits decisions: BUCA, Reference-Based Pricing (RBP), Direct Contract Pricing, and Network.

A strong company culture is no longer just a “nice-to-have”—it’s essential for retaining top talent and staying competitive in today’s job market. When employees feel valued, supported, and connected to their workplace, they’re more likely to stay and thrive.

Here are 10 actionable ways to create a company culture that attracts and retains the best talent.

An estimated 18 million Americans – 7% of the country’s adults – can’t afford the medicine they need. And 1 in 10 admitted to skipping prescribed doses to make their medicine last longer. These statistics from mid-2021 aren’t improving. They paint a shocking portrait of the pharmaceutical situation.

Unsurprisingly then, reducing medical costs is one of the hottest topics in the country. When President Biden came to power, reducing health insurance and drug costs were the top two priorities citizens had for him.

Though not a politician, Mark Cuban’s new drug company is aiming to achieve the latter of those goals.